Published in J Neurochem on September 20, 2011
Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation. Acta Neuropathol (2013) 0.96
Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy. Cell Death Dis (2014) 0.83
The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease? Int J Alzheimers Dis (2012) 0.81
Phosphorylation of FE65 Ser610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer's disease amyloid precursor protein processing. Biochem J (2015) 0.79
FE65 and FE65L1 share common synaptic functions and genetically interact with the APP family in neuromuscular junction formation. Sci Rep (2016) 0.77
Our "energy-Ca(2+) signaling deficits" hypothesis and its explanatory potential for key features of Alzheimer's disease. Front Aging Neurosci (2014) 0.77
FE65 and FE65L1 amyloid precursor protein-binding protein compound null mice display adult-onset cataract and muscle weakness. FASEB J (2015) 0.77
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
APP processing and synaptic function. Neuron (2003) 8.37
Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron (2005) 7.53
Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol (1998) 7.27
An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science (1994) 5.10
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell (1989) 4.99
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature (2006) 4.54
Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell (1999) 3.58
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell (1995) 3.33
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci (2008) 3.25
Calpain and caspase: can you tell the difference? Trends Neurosci (2000) 3.14
Ionic dependence of glutamate neurotoxicity. J Neurosci (1987) 3.01
The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem (2001) 2.42
APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol (2003) 2.21
Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci (2009) 2.18
Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J Neurochem (1998) 1.95
Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci (2006) 1.94
Ubiquitin and protein turnover in synapse function. Neuron (2005) 1.78
Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci (2009) 1.65
Metalloproteomes: a bioinformatic approach. Acc Chem Res (2009) 1.52
Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. EMBO J (2006) 1.51
Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk? Exp Neurol (2004) 1.50
The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J Neurosci (2003) 1.50
Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci (2009) 1.47
NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci (2005) 1.44
Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem (1999) 1.38
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci (2009) 1.37
The beta A4 amyloid precursor protein binding to copper. FEBS Lett (1994) 1.34
Physiological regulation of the beta-amyloid precursor protein signaling domain by c-Jun N-terminal kinase JNK3 during neuronal differentiation. J Neurosci (2005) 1.34
Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments. J Biol Chem (2002) 1.31
Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1. J Cell Biol (2005) 1.28
Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production. J Neurosci (2010) 1.26
The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem (2009) 1.25
Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci (2007) 1.23
The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev Biol (1994) 1.19
Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J Biol Chem (1992) 1.18
The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem (2001) 1.16
APP anterograde transport requires Rab3A GTPase activity for assembly of the transport vesicle. J Neurosci (2009) 1.13
Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1. J Biol Chem (2003) 1.12
Isoform-specific knockout of FE65 leads to impaired learning and memory. J Neurosci Res (2004) 1.11
Post-translational processing and turnover kinetics of presynaptically targeted amyloid precursor superfamily proteins in the central nervous system. J Biol Chem (1998) 1.09
HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. J Biol Chem (2007) 1.09
APP at a glance. J Cell Sci (2007) 1.04
A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol Dis (2002) 1.04
Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density. Brain Res Mol Brain Res (1995) 1.03
Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. Biochem Biophys Res Commun (1989) 0.99
Proteolytic processing of beta-amyloid precursor by calpain I. J Neurosci (1990) 0.97
hFE65L influences amyloid precursor protein maturation and secretion. J Neurochem (1999) 0.91
Embryonic stem cell-derived neurons as a cellular system to study gene function: lack of amyloid precursor proteins APP and APLP2 leads to defective synaptic transmission. Stem Cells (2008) 0.91
Expression of L-APP mRNA in brain cells. Ann N Y Acad Sci (1993) 0.81
Reduced amyloidogenic processing of the amyloid beta-protein precursor by the small-molecule Differentiation Inducing Factor-1. Cell Signal (2008) 0.79
The chondroitin sulfate attachment site of appican is formed by splicing out exon 15 of the amyloid precursor gene. J Biol Chem (1995) 0.79
Inhibition of neuronal calcium oscillations by cell surface APP phosphorylated on T668. Neurobiol Aging (2010) 0.78
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A (2003) 5.44
Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol (2004) 3.24
PPSP: prediction of PK-specific phosphorylation site with Bayesian decision theory. BMC Bioinformatics (2006) 2.34
Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci U S A (2007) 2.05
Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci U S A (2003) 2.02
Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex. Nat Neurosci (2006) 1.86
Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. EMBO J (2006) 1.51
Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. J Neurochem (2007) 1.19
Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides. FASEB J (2006) 1.14
Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1. J Biol Chem (2003) 1.12
HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. J Biol Chem (2007) 1.09
Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones. J Neurosci (2010) 1.07
APP at a glance. J Cell Sci (2007) 1.04
The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol (2004) 1.02
GPU accelerated chemical similarity calculation for compound library comparison. J Chem Inf Model (2011) 0.95
Comparative population genomics reveals the domestication history of the peach, Prunus persica, and human influences on perennial fruit crops. Genome Biol (2014) 0.94
Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J Biol Chem (2013) 0.93
Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor. Int Immunopharmacol (2011) 0.93
Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential. Future Med Chem (2012) 0.90
Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors. J Med Chem (2012) 0.89
Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging. ACS Nano (2013) 0.89
Random Walk and Graph Cut for Co-Segmentation of Lung Tumor on PET-CT Images. IEEE Trans Image Process (2015) 0.89
Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors. Biochemistry (2012) 0.88
Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs. J Chem Inf Model (2014) 0.88
An update on the amyloid hypothesis. Neurol Clin (2007) 0.87
FE65 as a link between VLDLR and APP to regulate their trafficking and processing. Mol Neurodegener (2012) 0.86
64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. J Med Chem (2014) 0.84
Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions. Mol Pharm (2012) 0.84
Diverging DOS strategy using an allene-containing tryptophan scaffold and a library design that maximizes biologically relevant chemical space while minimizing the number of compounds. ACS Comb Sci (2011) 0.84
Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease. J Alzheimers Dis (2013) 0.83
SDED: a novel filter method for cancer-related gene selection. Bioinformation (2008) 0.82
Molecular diagnosis of alpha-thalassemia by combining real-time PCR with SYBR Green1 and dissociation curve analysis. Transl Res (2006) 0.82
Amyloid beta a4 precursor protein-binding family B member 1 (FE65) interactomics revealed synaptic vesicle glycoprotein 2A (SV2A) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) as new binding proteins in the human brain. Mol Cell Proteomics (2013) 0.82
AlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research. J Chem Inf Model (2014) 0.82
Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluation. J Med Chem (2013) 0.82
The clinical significance of sperm DNA damage detection combined with routine semen testing in assisted reproduction. Mol Med Rep (2011) 0.81
A targeted library screen reveals a new inhibitor scaffold for protein kinase D. PLoS One (2012) 0.80
Ligand Classifier of Adaptively Boosting Ensemble Decision Stumps (LiCABEDS) and its application on modeling ligand functionality for 5HT-subtype GPCR families. J Chem Inf Model (2011) 0.80
Natural product extracts that reduce accumulation of the Alzheimer's amyloid beta peptide: selective reduction in A beta42. J Mol Neurosci (2002) 0.80
Determination of chitosan by cathodic stripping voltammetry. Anal Sci (2006) 0.78
LiCABEDS II. Modeling of ligand selectivity for G-protein-coupled cannabinoid receptors. J Chem Inf Model (2013) 0.78
Study on molecular epidemiology of the alpha-thalassemias in Liuzhou City, Guangxi Autonomous Region, China. Hemoglobin (2004) 0.78
Facile integration of multiple magnetite nanoparticles for theranostics combining efficient MRI and thermal therapy. Nanoscale (2015) 0.78
Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T1 contrast ability. Nanoscale (2016) 0.78
Comparative normal/failing rat myocardium cell membrane chromatographic analysis system for screening specific components that counteract doxorubicin-induced heart failure from Acontium carmichaeli. Anal Chem (2014) 0.77
Novel technique for rapid detection of alpha-globin gene mutations and deletions. Transl Res (2009) 0.77
A rapid detection for α-thalassemia by PCR combined with dissociation curve analysis. Exp Mol Pathol (2011) 0.77
Lifespan extension by n-butanol extract from seed of Platycladus orientalis in Caenorhabditis elegans. J Ethnopharmacol (2013) 0.77
An assay of gene copy number and its application based on heteroduplex products. Exp Mol Pathol (2011) 0.77
A comprehensive, simple molecular assay of common deletions and mutations causing alpha-thalassemia in Southeast Asia and southern China. Am J Hematol (2010) 0.77
Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing. J Neurochem (2010) 0.77
A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi'an. J Addict Med (2013) 0.76
Advances in recent patent and clinical trial drug development for Alzheimer's disease. Pharm Pat Anal (2014) 0.76
Synthesis and in silico screening of a library of β-carboline-containing compounds. Beilstein J Org Chem (2012) 0.76
Modeling skin sensitization potential of mechanistically hard-to-be-classified aniline and phenol compounds with quantum mechanistic properties. BMC Pharmacol Toxicol (2014) 0.75
Construction of a spirooxindole amide library through nitrile hydrozirconation-acylation-cyclization cascade. ACS Comb Sci (2013) 0.75
ProSelection: A novel algorithm to select proper protein structure subsets for in silico target identification and drug discovery research. J Chem Inf Model (2017) 0.75
Software configurable optical test system: a computerized reverse Hartmann test. Appl Opt (2010) 0.75
High sensitive trap loss spectroscopic detection of the lowest vibrational levels of ultracold molecules. Phys Chem Chem Phys (2011) 0.75
High-efficiency third harmonic generation at 355nm based on La2CaB10O19. Opt Express (2011) 0.75
Growth and optical properties of a new nonlinear Na(3)La(9)O(3)(BO(3))(8) crystal. Opt Express (2010) 0.75
Polarographic determination of total iron content using a Fe(2+/3+)-Methylthymol Blue-NO2- system. Anal Sci (2004) 0.75
A novel large deletion causing Hb Bart's Hydrops Fetalis in South China. Ann Hematol (2010) 0.75
Dispersion relations of refractive indices suitable for KBe<sub>2</sub>BO<sub>3</sub>F<sub>2</sub> crystal deep-ultraviolet applications. Appl Opt (2016) 0.75
Detection of a novel large deletion causing α-thalassemia in South China. Exp Mol Pathol (2013) 0.75
Arbitrarily copropagating superluminal and slow light by controllable one-photon detuning in trapped cold atoms. Opt Express (2008) 0.75
Identification of a novel substrate for tyrosine kinase in human testes. J Nanosci Nanotechnol (2005) 0.75
Activatable T1 Relaxivity Recovery Nanoconjugates for Kinetic and Sensitive Analysis of Matrix Metalloprotease 2. ACS Appl Mater Interfaces (2017) 0.75
High sensitive determination of laser-induced frequency shifts of ultracold cesium molecules. Opt Lett (2011) 0.75
Detection of α-globin gene deletions using denaturing high-performance liquid chromatography and multiplex ligation-dependent probe amplification. J Clin Lab Anal (2011) 0.75
High-average-power 266 nm generation with a KBe₂BO₃F₂ prism-coupled device. Opt Express (2014) 0.75
Phosphorylation site prediction with a modified k-nearest neighbor algorithm and BLOSUM62 matrix. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Improvement in the detection of alpha0- and deletional alpha-thalassemia by real-time PCR combined with dissociation curve analysis. Acta Haematol (2009) 0.75
High-power picosecond 355 nm laser based on La₂CaB₁₀O₁₉ crystal. Opt Lett (2014) 0.75
A 7.81 W 355 nm ultraviolet picosecond laser using La2CaB10O19 as a nonlinear optical crystal. Opt Express (2014) 0.75
Tape Assisted Photolithographic-free Microfluidic Chip (TAPMiC) Cell Patterning for Tumor Metastasis Study. Anal Chem (2017) 0.75